Navigation Links
Drug Combination Highly Effective for Newly Diagnosed Myeloma Patients, Study Finds
Date:12/12/2011

SAN DIEGO, Dec. 12, 2011 /PRNewswire/ -- A three-drug combination treatment for the blood cancer multiple myeloma compares favorably to the best established therapy for newly diagnosed patients, according to a multi-center study led by Andrzej Jakubowiak, MD, PhD, professor of medicine and director of the multiple myeloma program at the University of Chicago Medical Center.

Jakubowiak will present final results of the phase I-II study on Dec. 12, 2011, at the American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, Calif. The initial results from phase I of this study were presented at the ASH Meeting 2010 and were selected for the Best of ASH 2010 session.

The combination includes an investigational medicine called carfilzomib combined with two standard medications: lenalidomide, an analogue of thalidomide, and low-dose dexamethasone, an anti-inflammatory with anti-cancer properties.

"This combination appears to deliver everything we expected and more," said Jakubowiak, who came to the University of Chicago this fall from the University of Michigan. "We have seen excellent efficacy — the best reported to date — without the neurotoxicity that has been problematic with other drug combinations."

Multiple myeloma is a type of cancer that arises in plasma cells, the bone marrow component that produces antibodies. The American Cancer Society estimates that about 20,520 Americans will be diagnosed with multiple myeloma in 2011 and 10,610 will die from the disease.

The research team enrolled 53 people at three different carfilzomib dose levels. Most patients responded quickly t
'/>"/>

SOURCE University of Chicago Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bayers Drospirenone-containing Combination Oral Contraceptives: FDA Advisory Committees Affirm Positive Benefit-risk Profile and Recommend an Update of Labels to Reflect Information From Available Studies
2. Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS
3. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
4. Takeda Submits New Drug Application in the U.S. for Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin
5. Merrimack Pharmaceuticals Initiates Enrollment in Phase 2 Study of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer
6. New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
7. Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
8. FDA Approves Combination Therapy Juvisync
9. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
10. Interim Data Announced for BIBF 1120 as Compared to bevacizumab in Combination Chemotherapy in Metastatic Colorectal Cancer
11. New Combination Locking Cap Designed to Protect Children and Teens From Prescription Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... -- San MediTech, the industry leader in ... diabetics, announced its plan to attend the American Diabetes ... on June 5 th to 8 ... System (DGMS). The company plans to show industry experts ... and advancements made by Chinese medical device companies. San ...
(Date:6/2/2015)... today they are expanding their reach nationally by providing customers with on-site 17025 accredited pipette calibrations. ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 ...
(Date:6/2/2015)... LOS ANGELES , June 2, 2015  CytRx ... development company specializing in oncology, today announced that it ... action pending in the Delaware ... of the Company,s current and former directors and officers, ... The lawsuit, captioned In re CytRx Corp. ...
Breaking Medicine Technology:San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 4Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4
... MYL ) today commented on its response ... Mylan CEO Heather Bresch said, "We recognize the ... of patients with cancer, particularly the pediatric population, and ... to this important product. While Mylan has not had ...
... IRVINE, Calif., Feb. 14, 2012 Masimo (NASDAQ: ... its mission to "Improve Patient Outcomes and Reduce the Cost ... Applications®," and its confidence that continuous noninvasive hemoglobin monitoring (SpHb®) ... hospital-wide risk-share program for B lood T ransfusion ...
Cached Medicine Technology:Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 2Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 3Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 4Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 5Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 6Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 7
(Date:6/2/2015)... ANT Wireless, proven innovator in ultra-low ... (NPE) announcement of three next generation WASP bridge ... WASP-PoE-3. WASP is a standalone ANT (covering ANT, ... that allows data collected from low-power wireless sensors ... , The new generation of WASP ...
(Date:6/2/2015)... CRN International has been named a 2015 ... , a Connecticut state program that takes active steps to ... at appropriate companies. , Platform to Employment is being delivered ... Department of Labor. CRN, a 40-year-old radio marketing company near ... being recognized for its “hard work and dedication.” , CRN ...
(Date:6/2/2015)... Shimadzu Scientific Instruments today announces ... spectrometer. The newest model in the Ultra-Fast Mass ... ultrafast technologies (UF technologies) with new ion guide ... quality and higher throughput for a wide array ... features new technology, including a stronger vacuum system ...
(Date:6/2/2015)... 2015 DuPont Pioneer , one ... new seed warehouse and office facility in Zambia that ... for both local and export markets to Kenya, Tanzania ... emerge as the breadbasket for southern Africa provided an ... and South Central Africa senior business manager of DuPont ...
(Date:6/2/2015)... 2015 PhishLine, LLC today announced ... Swenson Drive, Suite 125 in Waukesha, Wisconsin 53186. ... new base of operations for PhishLine’s current corporate ... growth. , Mark Chapman, Founder and President, commented ... as enterprise customers adopt our market leading service ...
Breaking Medicine News(10 mins):Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3Health News:CRN Named Company Partner of the Year by CT Employment Program 2Health News:Shimadzu’s New LC-MS/MS Provides Superior Speed and Sensitivity for the Utmost in Quantitative Detection and High-Speed Analysis 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 3Health News:PhishLine, LLC Announces New Corporate Headquarters 2
... 19 California attorneys and a,presiding judge are among ... assemble next month in Los Angeles to discuss emerging ... Robert Berkes of Berkes Crane Robinson ... on asbestos litigation; Steven Kazan of Kazan McClain,Abrams Lyons ...
... (TSX: IM) ("IMRIS" or the "Company") today announced ... development and commercialization of MR-guided radiation therapy and ... (UHN) in Toronto. , The collaboration signals the ... guided radiation therapy, expanding on its existing expertise ...
... Feb. 19 The March of Dimes New York Division announced ... will return for a second year, to lead March for Babies(R) ... CBS 2 News Co-Anchor, Maurice DuBois , WCBS-TV/CBS 2 Sports ... morning program. "I,m very excited to be working with March of ...
... Region that affects addictive behavior is linked to ... (HealthDay News) -- The thrill-seeking behavior that makes ... might be based in an area of the ... , University of Kentucky and Purdue University researchers ...
... not possible, transplanting stem cells from the patient,s own bone marrow ... , The procedure has been tested successfully in ... been shown in 80% of cases, and considerable improvement in quality ... Hospital Clnic has used this therapy in a total of 6 ...
... Awards In January; Additional Cash Prizes Go to Support Best ... WarriorsWHITE PLAINS, N.Y., Feb. 19 Americans, renewed sense of ... the way to online solitaire. Thousands of ... games on behalf of their favorite charity or community organization. ...
Cached Medicine News:Health News:California Attorneys Featured at Major Asbestos Litigation Event 2Health News:IMRIS announces development program for MR guided radiation and interventional applications 2Health News:Eli Manning to Lead March for Babies(R) in Manhattan 2Health News:Thrill-Seekers' Brains May Be Wired Differently 2Health News:New therapy with stem cells to treat Crohn's disease 2Health News:New therapy with stem cells to treat Crohn's disease 3Health News:New therapy with stem cells to treat Crohn's disease 4Health News:New therapy with stem cells to treat Crohn's disease 5Health News:Casual Gamers Join Forces With Top Charities to Compete for IWON.com Cash Prizes 2Health News:Casual Gamers Join Forces With Top Charities to Compete for IWON.com Cash Prizes 3
... midi gel dryer can dry 6 pieces of 10 ... area is 21 x 31 cm for laboratories to ... of silicon rubber with mask. Microprocessor controller controls temperature ... and the vacuum removes the moisture from below to ...
... To dry gels rapidly, evenly and safely, ... method. Heat and vacuum are applied beneath the ... Dries acrylamide and agarose gels up to 33 ... minutes., The heavy aluminum platen provides even heat ...
This double-up gel dryer system, 100-120 V, includes 2 Model 583 gel dryers, HydroTech™ vacuum pump, and double-up rack....
... The Model 583 gel dryer is an ... acrylamide and agarose gels and dries these gels ... The dryer incorporates lid-mounted heater elements which heat ... x 45 cm. This 220-240 V unit includes ...
Medicine Products: